Non-enzymatic AChE signaling

Non Enzymatic Ache Signaling enters the Adult Cognitive Disease corpus through the work of Susan Greenfield (submission 71), and is indexed here as one of the concepts that submission puts to work.

The argument it belongs to

Susan Greenfield's submission is summarised in this corpus as:

Alzheimer's disease is an aberrant form of neuronal development, where basal plate-derived subcortical neurons inappropriately reactivate a developmental growth signaling mechanism. The key molecule is T14, a 14-mer peptide cleaved from acetylcholinesterase (AChE), which acts on alpha-7 nicotinic receptors to trigger excitotoxic calcium influx, tau phosphorylation, and Abeta production in a self-perpetuating feedforward cycle.

Where it sits

The submission scores against the framework's convergence nodes as: cytoskeletal collapse 4 · compensatory paradigm 2 · neuroimmune interface 2 · endosomal nexus 1 · transcriptional / epigenetic 1.

Its declared subject matter: NBP6B-peptide, T14-alpha7-nAChR, therapeutic-antagonism, neurotoxin-targeting, T14-peptide, acetylcholinesterase, alpha7-receptor, developmental-biology, calcium-excitotoxicity, basal-plate-neurons, feedforward-toxicity, cyclic-peptide-therapy.

Named by the same submission

5 other concepts enter the corpus through the same paper, so they cover adjacent ground: Neurodegeneration as aberrant development · Region-selective neuronal vulnerability · T14 feedforward toxicity cascade · T14 Toxin Antagonism · Peptide Neurotherapeutics.

Assembled from the corpus rather than written: the summary is quoted from the submission that named it; the node scores are read from its dossier. It has not yet been expanded into an article.